Los Angeles-Area Myeloma Team

Michael Rosenzweig, M.D., is Chief, Division of Multiple Myeloma and a hematologist-oncologist, in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, CA.

Azra Borogovac, M.D., M.S., is a hematologist at City of Hope Orange County Lennar Foundation Cancer Center. For Dr. Borogovac, the patient is the most important part of the medical team. She sees the opportunity to provide care to people with cancer as a privilege. 

Scott Goldsmith, M.D., specializes in the treatment of multiple myeloma, which is also the focus of his prolific research.

Maung Myo Htut, M.D., is determined to find more effective treatments for multiple myeloma, a rare blood cancer that strikes about 30,000 Americans each year. He believes the body's own immune system may hold the key.

Murali Janakiram, M.D., M.S., is a hematologist-oncologist and associate professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Amrita Krishnan, M.D., directs the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope's cancer research hospital, seeking to make gains in one of the most rapidly changing areas in cancer research.

Sarah S. Lee, M.D., is an assistant clinical professor in the Department of Hematology & Hematopoietic Cell Transplantation, who studies precision therapy for plasma cell disorders like multiple myeloma and amyloidosis.

Nitya Nathwani, M.D., is an associate professor in Hematology & Hematopoietic Cell Transplantation and a hematologist/oncologist at City of Hope in Los Angeles, California.

Michael Rosenzweig, M.D., is Chief, Division of Multiple Myeloma and a hematologist-oncologist, in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, CA.